Your Biotech Outbound Pipeline. Fully Managed.
Leadriver builds, runs, and optimises your outbound SDR function for the Biotech market: from ICP targeting to booked meetings with VP Business Development, Heads of Commercial, Chief Scientific Officers, and Licensing Directors.
2-3x
60%
Lower cost than a full-time SDR
14
Days to first meetings
18+
Industries served
Why Biotech Outbound Fails for Most Teams
Life sciences buyers are highly selective and sceptical of outreach from vendors who do not understand clinical development timelines, regulatory pathways, or scientific rigour.
We write sequences that reference clinical development context, regulatory timelines, and scientific credibility: the language that opens doors in life sciences.
Life sciences purchasing often follows clinical or regulatory milestones. Without ongoing outbound activity aligned to those timelines, you miss the windows when buyers have budget and mandate to act.
We identify the right buyer at each company based on their development stage and your product's position in the value chain.
Biotech sales cycles are among the longest in B2B. Building internal outbound capability for this audience requires domain expertise that is rare and expensive to hire.
Every meeting handoff includes the prospect's pipeline context and development stage so your team leads with a precisely relevant case.
The right buyer in a life sciences organisation depends on whether the product touches R&D, clinical operations, regulatory affairs, or commercial launch. Each function has different priorities and different vocabulary.
We have run over 2,000 outbound campaigns across 18 industries and generated more than 85,000 interested leads. Our team understands the Biotech market and writes accordingly.
How We Run Your Biotech Outbound Engine
ICP Definition and Biotech Data Build
We work with you to define your ideal Biotech customer profile across company stage (pre-clinical, Phase I-III, commercial), therapeutic area, geography, and development programme pipeline. Then we build a verified, enriched lead list targeting VP Business Development, Heads of Commercial, Chief Scientific Officers, and Licensing Directors at your priority accounts.
Sequence Build and A/B Setup for Biotech
We write multi-touch email and LinkedIn sequences tailored to biotech buyers pain points and buying signals including clinical trial phase transitions, regulatory submissions, commercial launch preparation, and partnership or licensing rounds. Two variants run from day one so we optimise from the first week.
Launch and Warm-Up
We handle full technical setup: domain warm-up, inbox rotation, and deliverability monitoring. Outreach goes live within 14 days of onboarding with daily reporting from week one.
Optimise, Report, and Scale
Every week we review open rates, reply rates, and meeting rates for your Biotech sequences. Underperforming sequences get rewritten. What works gets scaled. You get a clear weekly report.
What Happens When Biotech Outbound Is Done Properly
in 90 days
For a clinical data management platform targeting VP Clinical Operations and Heads of Data Management at Phase II and III biotech companies across Europe.
Clinical Data / Biotech
in two quarters
A regulatory submission platform targeting Heads of Regulatory Affairs at mid-size specialty pharma companies generated two enterprise contracts from a 180-day programme.
Regulatory Tech / Biotech
to first meeting
A clinical trial management platform booked its first qualified VP Clinical Operations conversation within 16 days of launching outbound.
CTMS / Biotech
Common Questions About Outsourced SDR for Biotech
Ready to Fill Your Biotech Pipeline?
Book a 30-minute discovery call. We will show you how many qualified biotech buyers exist in your target market and what a realistic outbound programme looks like for your business.
Book Your Discovery Call